Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Sept. 16 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... Read More

Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Sept. 16 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... Read More

Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, Sept. 16 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus A... Read More

Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Sept. 16 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... Read More

Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Sept. 16 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the e... Read More

Keralam is India's oldest state, and it's getting older: What its proposed elderly care law would do

India, Sept. 16 -- The Keralam government said on Tuesday it was drafting a law to regulate how the elderly are looked after in the state. This involves who may run an elderly care home, who is qualif... Read More

Clinical Trial: A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820891) titled 'A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395' on Sept... Read More

Clinical Trial: Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patients With Endometriosis

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07821320) titled 'Impact of the Antihistamine Desloratadine on the Quality of Life and Dysmenorrhea in Patie... Read More

Clinical Trial: Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum Infection

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07819825) titled 'Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum Infection... Read More

Clinical Trial: DEVELOPMENT OF TRAINING PROTOCOL AND APPLICATION FOR SPEECH LANGUAGE PATHOLOGISTS ON TELETHERAPY: A CONTEMPORARY APPROACH TO SPEECH LANGUAGE THERAPY

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820982) titled 'DEVELOPMENT OF TRAINING PROTOCOL AND APPLICATION FOR SPEECH LANGUAGE PATHOLOGISTS ON TELET... Read More

• ««
• «
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• »
• »»